Similar articles

• An autopsy case of acute pulmonary toxicity associated with gemcitabine.

  Maniwa K, Tanaka E, Inoue T, Kato T, Sakuramoto M, Minakuchi M, Maeda Y, Noma S, Kobashi Y, Taguchi Y. Maniwa K, et al. Intern Med. 2003 Oct;42(10):1022-5. doi: 10.2169/internalmedicine.42.1022. Intern Med. 2003. PMID: 14606719 Review.
• Hemolytic-uremic syndrome associated with gemcitabine treatment for metastatic pancreatic cancer.

  Boeck S, Geiger S, Schulz C, Heinemann V. Boeck S, et al. J Clin Gastroenterol. 2008 May-Jun;42(5):551-2. doi: 10.1097/MCG.0b013e31802da22e. J Clin Gastroenterol. 2008. PMID: 18344882 No abstract available.
• Sudden cardio-pulmonary toxicity following a single infusion of gemcitabine.

  Ciotti R, Belotti G, Facchi E, Cantù A, D'Amico A, Gatti C. Ciotti R, et al. Ann Oncol. 1999 Aug;10(8):997. doi: 10.1023/a:1008305716918. Ann Oncol. 1999. PMID: 10509166 No abstract available.
• Favorable outcome of gemcitabine-induced respiratory distress syndrome.

  Girard T, Mouthon L, Boaziz C, Andre MH, Guillevin L. Girard T, et al. Ann Med Interne (Paris). 2000 Jun;151(4):306-8. Ann Med Interne (Paris). 2000. PMID: 10922960
• Gemcitabine-associated thrombotic thrombocytopenic purpura.

  Zupancic M, Shah PC, Shah-Khan F. Zupancic M, et al. Lancet Oncol. 2007 Jul;8(7):634-41. doi: 10.1016/S1470-2045(07)70203-6. Lancet Oncol. 2007. PMID: 17613425 Review.